Stock Taper 
PARADIGM BIOCAPITAL ADVISORS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Alnylam Pharmaceuticals, Inc. | ALNY | 480K | $144.49M |
 MapLight Therapeutics, Inc. | MPLT | 685.85K | $24.58M |
 Kardigan, Inc. | KARD | 900K | $21.46M |
 Insmed Incorporated | INSM | 1.33M | $141.38M |
 Apogee Therapeutics, Inc. | APGE | 1.58M | $209.23M |
 Tyra Biosciences, Inc. | TYRA | 1.83M | $58.41M |
 Vaxcyte, Inc. | PCVX | 2.13M | $123.69M |
 Oruka Therapeutics, Inc. | ORKA | 2.14M | $204.09M |
 Tarsus Pharmaceuticals, Inc. | TARS | 2.78M | $174.7M |
 Jade Biosciences, Inc. | JBIO | 2.86M | $63.49M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 2.89M | $41.33M |
 Spyre Therapeutics, Inc. | SYRE | 3.84M | $340.98M |
 Editas Medicine, Inc. | EDIT | 5.59M | $18.1M |
 Tango Therapeutics, Inc. | TNGX | 6.36M | $198.74M |
 Revolution Medicines, Inc. | RVMD | 6.36M | $1.19B |
 Viridian Therapeutics, Inc. | VRDN | 6.72M | $123.52M |
 Olema Pharmaceuticals, Inc. | OLMA | 8.67M | $108.47M |
 Erasca, Inc. | ERAS | 9.55M | $174.96M |
 Edgewise Therapeutics, Inc. | EWTX | 10.22M | $415.05M |
 Genmab A/S | GMAB | 13.13M | $360.77M |